Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Fosun Pharma Drops in First Day of Hong Kong Trading

publication date: Oct 30, 2012
Fosun Pharma posted a loss in its first day of trading in Hong Kong, falling 8% from its IPO price to close at HK$10.84 (US$1.40). It hit an intraday low of HK$10.38. The IPO was priced HK$11.80, the low end of the range, which put the H-shares at a 13% discount from the Shanghai-listed price. The company’s stock may do better in the rest of the week. After the markets closed, Fosun reported its Q3 net income rose 95% on a 27% increase in revenues. More details....

Stock Symbol: (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital